Cost-Utility Analysis of Treatment with Olanzapine Compared with Other Antipsychotic Treatments in Patients with Schizophrenia in the Pan-European SOHO Study

By Knapp Martin   Windmeijer Frank  

PharmacoEconomics, Vol. 26, Iss. 4, 2008-01 ,pp. : 341-358

Adis International

Access to resources Recommend Favorite

Health economic considerations in the treatment of schizophrenia

By Souetre E.  

European Neuropsychopharmacology, Vol. 5, Iss. 3, 1995-09 ,pp. : 165-165

Elsevier

Access to resources Recommend Favorite

Progress in Defining Optimal Treatment Outcome in Schizophrenia

By Remington Gary   Foussias George   Agid Ofer  

CNS Drugs, Vol. 24, Iss. 1, 2010-01 ,pp. : 9-20

Adis International

Access to resources Recommend Favorite

Assessing Health Utilities in Schizophrenia: A Feasibility Study

By Voruganti L.N.  

PharmacoEconomics, Vol. 17, Iss. 3, 2000-03 ,pp. : 273-286

Adis International

Access to resources Recommend Favorite

Symptomatic remission in previously untreated patients with schizophrenia: 2-year results from the SOHO study

By Novick Diego   Haro Josep   Suarez David   Lambert Martin   Lépine Jean-Pierre   Naber Dieter  

Psychopharmacology, Vol. 191, Iss. 4, 2007-05 ,pp. : 1015-1022

Springer Publishing Company

Access to resources Recommend Favorite